)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Implantica
Implantica (IMP) investor relations material
Implantica Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary25 Feb, 2026
Executive summary
RefluxStop® is a breakthrough device for acid reflux, with over 1,500 procedures performed in 50 European hospitals and strong five-year clinical data showing high efficacy and safety.
FDA approval is in the final stages, with all pre-approval inspections completed and a U.S. launch targeted for 2026; launch preparations and production ramp-up to 10,000 units are advanced.
NICE endorsement in the U.K. and recent tender wins in Italy and Spain are driving gradual European market access, though reimbursement remains a bottleneck.
The withdrawal of LINX, a major competitor, from Europe is expected to benefit RefluxStop®'s uptake, but full impact depends on reimbursement progress.
RefluxStop® is recommended for NHS use in the UK for IEM reflux sufferers, marking a significant milestone for adoption.
Financial highlights
Q4 2025 net sales reached €530,000, up 20% year-over-year; full-year net sales grew 7% to €2.07 million.
Adjusted gross margin improved to 92% in Q4 and 93% for the year.
Q4 operating loss (EBIT) was €7.39 million, up 3% year-over-year, mainly due to R&D impairment; full-year operating loss narrowed to €20.52 million.
Year-end cash and short-term investments totaled €48.9 million, with no interest-bearing debt and an equity ratio of 96%.
Operating cash outflow for the year was €16.56 million, improved from €22.76 million prior year, reflecting disciplined cost management.
Outlook and guidance
FDA approval is expected in the near term, with a U.S. launch targeting 25-50 centers and a focus on rapid market penetration.
U.S. pricing is targeted at a premium (€8,800 per device), with plans to maintain high gross margins.
Production ramped up with 10,000 devices ready for initial U.S. launch and registry study.
European growth will remain gradual, dependent on reimbursement expansion; tender wins and code approvals are paving the way for broader adoption.
Expansion into Japan and Canada is planned post-U.S. approval, leveraging regulatory acceptance of FDA data.
Detail remaining FDA approval steps and timeline
Cash burn rate and future funding strategy
R&D pipeline realignment post-impairment
US launch: How to accelerate market penetration
Which EU country offers fastest reimbursement path?
How to unlock the 300k IEM patient market
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Implantica earnings date
Q1 202622 May, 2026
Implantica
Next Implantica earnings date
Q1 202622 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Implantica AG with headquarters in Horw/Luzern (Switzerland) is a company developing and distributing innovative solutions for reconstructive surgery. The company’s range of products includes implants based on the unique Zoladex® technology, which is used in a wide variety of applications such as industrial implants, biodegradable drug carriers and scaffolds. In addition Implantica provides best-in-class synthetic meshes for use in hernia repair procedures.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage